XOMA Corp Modification Agreements

9 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment to Officer Employment Agreement between XOMA Corporation and Thomas Burns (November 1, 2022)
Modification Agreements
XOMA Corp
Biotechnology
2023
Amendment and Restatement to Asset Purchase and License Agreements between XOMA Corporation and Nanotherapeutics, Inc.
Modification Agreements
XOMA Corp
Biotechnology
2022
Amendment to CD40 Research, Development and Commercialization Agreement between Novartis Vaccines and Diagnostics, Inc. and XOMA (US) LLC
Modification Agreements
XOMA Corp
Biotechnology
2020
First Amendment to Loan and Security Agreement between Silicon Valley Bank and XOMA Corporation (and Affiliates)
Modification Agreements
XOMA Corp
Biotechnology
2019
Amendment to Secured Note Agreement between XOMA (US) LLC and Novartis Institutes for BioMedical Research, Inc.
Modification Agreements
XOMA Corp
Biotechnology
2018
Amendment to CD40 Research, Development and Commercialization Agreement between Novartis Vaccines and Diagnostics, Inc. and XOMA (US) LLC
Modification Agreements
XOMA Corp
Biotechnology
2015
Secured Note Agreement Maturity Date Extension between Novartis Vaccines and Diagnostics, Inc. and XOMA (US) LLC
Modification Agreements
XOMA Corp
Biotechnology
2015
Second Modification to NIH Contract HHSN272200800028C with XOMA (US) LLC
Modification Agreements
XOMA Corp
Biotechnology
2010
Amendment and Release Agreement Related to Lucentis License and Raptiva Collaboration (XOMA Bermuda, XOMA US, and Genentech)
Modification Agreements
XOMA Corp
Biotechnology
CA
2009